118th Congress Health
H.R. 384: Protecting Life from Chemical Abortions Act
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.
In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers.
Read the full summary
The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.
The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Robert Aderholt R-ALOriginal
- Lauren Boebert R-COOriginal
- Brian Babin R-TXOriginal
- Jim Banks R-INOriginal
- James Baird R-INOriginal
- Andrew Clyde R-GAOriginal
- Ben Cline R-VAOriginal
- Jeff Duncan R-SCOriginal
- Jake Ellzey R-TXOriginal
- Randy Feenstra R-IAOriginal
- Brad Finstad R-MNOriginal
- Russell Fry R-SCOriginal
- Paul Gosar R-AZOriginal
- Glenn Grothman R-WIOriginal
- Mark Green R-TNOriginal
- Michael Guest R-MSOriginal
- Diana Harshbarger R-TNOriginal
- Ashley Hinson R-IAOriginal
- Ronny Jackson R-TXOriginal
- Trent Kelly R-MSOriginal
- Doug Lamborn R-COOriginal
- Doug LaMalfa R-CAOriginal
- Barry Loudermilk R-GAOriginal
- Nicholas Langworthy R-NYOriginal
- John Moolenaar R-MIOriginal
- Brian Mast R-FLOriginal
- Mary Miller R-ILOriginal
- August Pfluger R-TXOriginal
- John Rutherford R-FLOriginal
- John Rose R-TNOriginal
- Pete Sessions R-TXOriginal
- Daniel Webster R-FLOriginal
- Randy Weber R-TXOriginal
- Brad Wenstrup R-OHOriginal
- Mike Bost R-IL
- Robert Good R-VA
- Keith Self R-TX
- Rudy Yakym R-IN
- Dan Crenshaw R-TX
- Dan Newhouse R-WA
Who scored on this bill
- 1Kevin Hern SponsorReached a cosponsor milestone, introduced2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Kevin Hern
History
- Introduced in the House by Kevin Hern.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.